Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Schmallenberg Virus found in UK cattle
AHVLA also confirms 29 sheep farms now infected

The Schmallenberg Virus (SBV) has been identified in cattle in UK territory for the first time after the Animal Health and Veterinary Laboratories Agency (AHVLA) confirmed the presence of the virus in cattle from a West Sussex farm. The disease is known to affect many ruminants, but all previous infections in cattle were in Belgium, Holland and Germany. Additional tests on this positive sample are in progress.

Previously, all confirmed cases in UK territory have been in sheep. AHVLA also announced a dramatic increase in the number of confirmed cases in UK sheep. The current count of confirmed cases has jumped from 11 last week to a total of 29. The 29 cases are in Norfolk, Suffolk, Essex, Kent, East Sussex, West Sussex and Hertfordshire, indicating that the number of counties affected by the virus has also expanded to include West Sussex and Hertfordshire. The above counties are all in areas that were always believed to be at risk in light of the hypothesis that the disease was spread by infected midges being blown across the North Sea and English Channel by prevailing winds last summer.

Surveillance for the infection has been escalated across the UK and the number of samples submitted to AHVLA for confirmation continues to increase. However, many vets have warned that the number of confirmed cases does not reflect the true extent of the outbreak and that, due to the mild nature of immediate symptoms and the more severe but later stillbirths and congenital defects, it will only be possible to gauge the scale of the outbreak at lambing or calving.

AHVLA have confirmed that they believe this development is ‘in line with our current understanding of SBV’ but have warned that the risk the virus poses ‘might increase as new information becomes available about the extent of infection in Europe’. Once again, AHVLA have stressed that current thinking does not consider SBV to be dangerous to humans and that there have been no reports of  zoonotic infections. Nevertheless, investigations are in progress on a precautionary basis. “As this is a new virus, work is ongoing to identify whether it could cause any health problems in humans,” it said.

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com